Your email has been successfully added to our mailing list.

×
0 3.19186287757997E-05 0.00063837257551418 0.000329825830682377 0.00352168870825316 0.00192575726946777 0.00290459521858943 4.2558171701026E-05
Stock impact report

Florida Cancer Specialists & Research Institute Contributes to Phase 1 Study Demonstrating Antitumor Activity with First-in-Class KRAS-Targeted Therapy for Treatment of Lung and Pancreatic...

HCA Healthcare, Inc. (HCA) 
Last hca healthcare, inc. earnings: 4/21 08:30 am Check Earnings Report
US:NYSE Investor Relations: investor.hcahealthcare.com
Company Research Source: Yahoo! Finance
April 2, 2026 /PRNewswire/ -- Results of a Phase 1 clinical study conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS) have provided significant insights into the safety and efficacy of setidegrasib in patients with advanced non-small-cell lung cancer and pancreatic cancer with KRAS G12D mutations. Setidegrasib is a first-in-class therapy that targets and breaks down KRAS G12D, a genetic mutation that can drive the growth of certain cancers. FCS Associate Director of Drug Development Judy Wang, MD is a co-author of the study, recently published in the New England Journal of Medicine. FCS Contributes to Phase 1 Study Demonstrating Antitumor Activity with First-in-Class KRAS-Targeted Therapy for Treatment of Lung and Pancreatic Cancers "These results signify a major milestone in oncology and first proof of concept for targeted KRAS G12D, a genetic mutation long considered difficult to treat," notes Cesar Augusto Perez, MD , director of the Dru Show less Read more
Impact Snapshot
Event Time:
HCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for HCA alerts
Opt-in for
HCA alerts

from News Quantified
Opt-in for
HCA alerts

from News Quantified